1. Discussing the role of ECs or angiocrine factors secreted by them in organ regeneration. 2. Discussing the use of novel delivery platforms to upregulate genes of interest and to stimulate organ regeneration including modified mRNA, TALEN technology and optogenetics. 3. Discussing the use of in vivo molecular imaging technology to visualize stem cell-derived tissues following transplantation. 4. Discussing the use of biomaterials to make biological scaffolds for stem cell-based therapies and organ-on-a-chip applications. 5. Discussing up-to-date knowledge in epigenetic regulation of PSCs in cell fate specification and maturation. 6. Discussing the immunological hurdles and strategies to induce transplantation tolerance to PSCderived tissues for stem cell-based therapies. 
